Profiles

Keywords
Last Name
Institution

Ruta Rao

TitleAssociate Professor
InstitutionRush University, Rush Medical College
DepartmentInternal Medicine, Division of Hematology/Oncology/Cell Therapy
AddressChicago IL 60612
Phone312-942-3324
Fax312-942-3192
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 35332886000.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Schermerhorn MC, Grunvald MW, O'Donoghue CM, Rao RD, Becerra AZ. ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays. Ann Surg Oncol. 2022 Jul 04. PMID: 35789306.
      View in: PubMed
    2. Schermerhorn MC, Grunvald MW, O'Donoghue CM, Rao RD, Becerra AZ. Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer. Ann Surg Oncol. 2022 Jun 24. PMID: 35751007.
      View in: PubMed
    3. Grunvald MW, Williams MD, Rao RD, O'Donoghue CM, Becerra AZ. 100 Disruptive Publications in Breast Cancer Research. Asian Pac J Cancer Prev. 2021 Aug 01; 22(8):2385-2389. PMID: 34452550.
      View in: PubMed
    4. Chowdhary M, Sen N, Chowdhary A, Usha L, Cobleigh MA, Wang D, Patel KR, Barry PN, Rao RD. Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination. Adv Radiat Oncol. 2019 Jul-Sep; 4(3):453-457. PMID: 31360799.
      View in: PubMed
    5. Rao RD, Cobleigh MA. Adjuvant endocrine therapy for breast cancer. Oncology (Williston Park). 2012 Jun; 26(6):541-7, 550, 552 passim. PMID: 22870539.
      View in: PubMed
    6. Rao RD, Cobleigh MA, Gray R, Graham ML, Norton L, Martino S, Budd GT, Ingle JN, Wood WC. Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group. Med Oncol. 2011 Dec; 28 Suppl 1:S39-47. PMID: 20878269.
      View in: PubMed
    7. Chen SS, Strauss JB, Shah AP, Rao RD, Bernard DA, Griem KL. Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy. 2009 Jul-Sep; 8(3):331-4. PMID: 19446501.
      View in: PubMed
    8. Usha L, Tabesh B, Morrison LE, Rao RD, Jacobson K, Zhu A, Basu S, Coon JS. Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts. J Hematol Oncol. 2008 Aug 14; 1:12. PMID: 18702822.
      View in: PubMed
    9. Morrison LE, Jewell SS, Usha L, Blondin BA, Rao RD, Tabesh B, Kemper M, Batus M, Coon JS. Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer. 2007 Apr; 46(4):397-405. PMID: 17243161.
      View in: PubMed
    10. Rao SN, Rao RD. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Cornea. 2006 Jul; 25(6):674-8. PMID: 17077659.
      View in: PubMed
    Rao's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (63) concept(s)
    _
    Co-Authors Expand Description
    See all (4) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department